Teologo, Alvi Jane .
HRN: 28-71-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2026
AMPICILLIN 1GM (VIAL)
03/21/2026
03/27/2026
IV
2g
Q6hr
PROM, Thinly MSAF
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: